The first patient in India to receive this therapy was through Dr V. Mohan, chairman and chief of diabetology, Dr Mohan’s Diabetes Specialities Center, Chennai
Medtronic has announced the launch of MiniMed 780G system in India. It is a closed loop insulin pump system for the treatment of type 1 diabetes in people age 7 to 80 years. Leveraging the company’s SmartGuard technology, the system automates the delivery of both basal insulin and correction boluses every five minutes to help people with diabetes avoid highs and lows with greater ease. The first patient in India to receive this therapy was through Dr V. Mohan, chairman and chief of diabetology, Dr Mohan’s Diabetes Specialities Center, Chennai.
“No two days are alike when it comes to blood glucose levels in people with type 1 diabetes and this variability presents a huge challenge that can increase burden for the patients, caregivers, doctors and others. With the new MiniMed 780G system patients can reduce such variability and aim to maintain glucose levels within defined parameters leading to near normal life. This technology can help reduce the burden for people living with diabetes while driving better clinical outcomes,” said Dr Mohan.
Chandra Shekhar Jaiman, head of Specialty Therapies, Medtronic India added, “Insulin pump therapy has a lot of potential for helping individuals with type 1 diabetes reach their glucose goals. The new MiniMed 780G system further simplifies diabetes management and adapts to a person’s life with the goal of enhancing their experience in a seamless way. The automation built into the MiniMed 780G system provides patients, caregivers & physicians a way to manage all the variables inherent with diabetes and achieve the optimal outcomes. With advancements in technology, we are seeking better outcomes for patients so they can focus on life and not glucose levels.”
The MiniMed 780G system enables the personalisation of glucose goals with an adjustable target setting as low as 100 mg/dL — lower than any other advanced hybrid closed loop system and is designed to help stabilise blood sugar levels and further improve glucose control. The system is part of the new Medtronic portfolio of insulin pumps with smartphone connectivity via Bluetooth technology. This advancement allows users and their care partners to see real-time glucose data and trends on compatible iOS and Android smartphones via apps. Additionally, healthcare providers will find that managing patients on the system is simple as there are only a few settings that need adjustment to enable optimal use of the technology.
- Advertisement -